{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T02:54:40Z","timestamp":1764557680476},"reference-count":17,"publisher":"Oxford University Press (OUP)","issue":"Supplement_B","license":[{"start":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T00:00:00Z","timestamp":1682035200000},"content-version":"vor","delay-in-days":20,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,4,21]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Coronary artery disease is the predominant aetiology of heart failure and left ventricular dysfunction in industrialized countries. The pathophysiological substrate of hibernating myocardium constitutes the conceptual target of coronary revascularization by coronary artery bypass graft (CABG) or coronary angioplasty or percutaneous coronary intervention (PCI). Studies, mainly observational, conducted in the past have demonstrated a prognostic benefit of CABG on survival. These findings were confirmed by the long-term follow-up of the STICH study in which, however, documentation of inducible ischaemia or myocardial viability was not predictive of a prognostic benefit of CABG. Revascularization via PCI in the recent REVIVED-BCIS2 study did not demonstrate a significant benefit in terms of death or heart failure hospitalization compared with optimal medical therapy. Pending the long-term follow-up of the REVIVED-BCIS2 study, optimized medical therapy, cardiac resynchronization therapy, and the implantable cardioverter defibrillator, where indicated, are the mainstay of treatment in patients with dilated ischaemic cardiomyopathy. The decision for coronary revascularization is made in the individual patient, possibly with a higher bias in patients with angina, three-vessel coronary artery disease, severe left ventricular dysfunction, and cardiac remodelling.<\/jats:p>","DOI":"10.1093\/eurheartjsupp\/suad072","type":"journal-article","created":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T18:02:51Z","timestamp":1682100171000},"page":"B75-B78","source":"Crossref","is-referenced-by-count":5,"title":["What is the role of coronary revascularization to recover the contractility of the dysfunctional heart?"],"prefix":"10.1093","volume":"25","author":[{"given":"Gloria","family":"Vassiliki\u2019 Cousoumbas","sequence":"first","affiliation":[{"name":"Cardiology Operating Unit, Ospedale Maggiore , Bologna"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianni","family":"Casella","sequence":"additional","affiliation":[{"name":"Cardiology Operating Unit, Ospedale Maggiore , Bologna"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Di Pasquale","sequence":"additional","affiliation":[{"name":"Coordination of the Cardiological and Cardiovascular Surgical Network , Emilia-Romagna"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2023,4,21]]},"reference":[{"key":"2023042117455168500_suad072-B1","first-page":"V123","article-title":"A perspective on the three large multicenter randomized clinical trials of coronary bypass surgery for chronic stable angina","volume":"72","author":"Rahimtoola","year":"1985","journal-title":"Circulation"},{"key":"2023042117455168500_suad072-B2","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1161\/01.CIR.68.4.785","article-title":"Results of coronary artery surgery in patients with poor left ventricular function (CASS)","volume":"68","author":"Alderman","year":"1983","journal-title":"Circulation"},{"key":"2023042117455168500_suad072-B3","doi-asserted-by":"crossref","first-page":"e003255","DOI":"10.1161\/CIRCHEARTFAILURE.116.003255","article-title":"Survival benefits of invasive versus conservative strategies in heart failure in patients with reduced ejection fraction and coronary artery disease: a meta-analysis","volume":"10","author":"Wolff","year":"2017","journal-title":"Circ Heart Fail"},{"key":"2023042117455168500_suad072-B4","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1093\/ejcts\/ezaa319","article-title":"Treatment strategies in ischaemic left ventricular dysfunction: a network meta-analysis","volume":"59","author":"Gaudino","year":"2021","journal-title":"Eur J Cardio Thoracic Surg"},{"key":"2023042117455168500_suad072-B5","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1056\/NEJMoa1100356","article-title":"Coronary-artery bypass surgery in patients with left ventricular dysfunction","volume":"364","author":"Velazquez","year":"2011","journal-title":"N Engl J Med"},{"key":"2023042117455168500_suad072-B6","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1056\/NEJMoa1602001","article-title":"Coronary artery bypass surgery in patients with ischemic cardiomyopathy","volume":"374","author":"Velazquez","year":"2016","journal-title":"N Engl J Med"},{"key":"2023042117455168500_suad072-B7","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.jacc.2014.04.064","article-title":"Extent of coronary and myocardial disease and benefit from surgical revascularization in LV dysfunction","volume":"64","author":"Panza","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2023042117455168500_suad072-B8","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/eurheartj\/ehy394","article-title":"2018 ESC\/EACTS guidelines on myocardial revascularization","volume":"40","author":"Neumann","year":"2019","journal-title":"Eur Heart J"},{"key":"2023042117455168500_suad072-B9","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1161\/CIRCULATIONAHA.120.050734","article-title":"Association of inducible myocardial ischemia with long-term mortality and benefit from coronary artery bypass graft surgery in ischemic cardiomyopathy","volume":"143","author":"O\u2019Fee","year":"2021","journal-title":"Circulation"},{"key":"2023042117455168500_suad072-B10","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jacc.2022.04.052","article-title":"Benefit of early revascularization based on inducible ischemia and left ventricular ejection fraction","volume":"80","author":"Rozanski","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"2023042117455168500_suad072-B11","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1093\/ehjci\/jeac125","article-title":"Impact of revascularization guided by functional testing in ischaemic cardiomyopathy","volume":"23","author":"Rodenas-Alesina","year":"2022","journal-title":"Eur Heart J Cardiovasc Img"},{"key":"2023042117455168500_suad072-B12","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1056\/NEJMoa1915922","article-title":"Initial invasive or conservative strategy for stable coronary disease","volume":"382","author":"Maron","year":"2020","journal-title":"N Engl J Med"},{"key":"2023042117455168500_suad072-B13","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1161\/CIRCULATIONAHA.120.050304","article-title":"Initial invasive versus conservative management of stable ischemic heart disease in patients with a history of heart failure or left ventricular dysfunction: insights from the ISCHEMIA trial","volume":"142","author":"Lopes","year":"2020","journal-title":"Circulation"},{"key":"2023042117455168500_suad072-B14","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/S0735-1097(02)01726-6","article-title":"Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis","volume":"39","author":"Allman","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"2023042117455168500_suad072-B15","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1056\/NEJMoa1807365","article-title":"Myocardial viability and long-term outcomes in ischemic cardiomyopathy","volume":"381","author":"Panza","year":"2019","journal-title":"N Engl J Med"},{"key":"2023042117455168500_suad072-B16","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1056\/NEJMoa2206606","article-title":"For the REVIVED-BCIS2 investigators.percutaneous revascularization for ischemic left ventricular dysfunction","volume":"387","author":"Perera","year":"2022","journal-title":"N Engl J Med"},{"key":"2023042117455168500_suad072-B17","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1056\/NEJMe2210183","article-title":"REVIVE-ing a weak heart\u2014details matter","volume":"387","author":"Kirtane","year":"2022","journal-title":"N. Engl J. Med"}],"container-title":["European Heart Journal Supplements"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartjsupp\/article-pdf\/25\/Supplement_B\/B75\/50061036\/suad072.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartjsupp\/article-pdf\/25\/Supplement_B\/B75\/50061036\/suad072.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T18:03:05Z","timestamp":1682100185000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartjsupp\/article\/25\/Supplement_B\/B75\/7135769"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,1]]},"references-count":17,"journal-issue":{"issue":"Supplement_B","published-online":{"date-parts":[[2023,4,21]]},"published-print":{"date-parts":[[2023,4,21]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartjsupp\/suad072","relation":{},"ISSN":["1520-765X","1554-2815"],"issn-type":[{"value":"1520-765X","type":"print"},{"value":"1554-2815","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,4,1]]},"published":{"date-parts":[[2023,4,1]]}}}